​

Funding Round

Venture Round - HilleVax

Venture Round - HilleVax

Investment Firm

Overview

HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.

Announced Date

Sep 08, 2021

Funding Type

Series Unknown

Highlights

Location

United States, North America

Social

Investor Lead

Frazier Healthcare Partners

Frazier Healthcare Partners

Frazier Healthcare Partners is a early_stage_venture and late_stage_venture and post_ipo and private_equity firm.

Participant Investors

12

Investor Name
Participant InvestorAbingworth
Participant InvestorDeerfield
Participant InvestorGreenspring Associates
Participant InvestorLightspeed Venture Partners
Participant InvestorFrazier Healthcare Partners

Round Details and Background

HilleVax raised $135000000 on 2021-09-08 in Venture Round

HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 08, 2021
Venture Round - HilleVax
14-135.0M
Sep 19, 2023
Post-IPO Equity - HilleVax
-100.0M

Recent Activity

There is no recent news or activity for this profile.